Publications by authors named "Raquel Lopez Ramon"

Claim this Profile
D
Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.
Mimi M Hou, Adam C Harding, Natalie M Barber, Prasun Kundu, Florian A Bach, Raquel Lopez Ramon

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mucosal responses following a randomised controlled human inhaled infection with attenuated Mycobacterium bovis BCG.
Julia L Marshall, Iman Satti, Mirvat Surakhy, Stephanie A Harris, Hazel Morrison, Raquel Lopez Ramon

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults.
Timothy Fredsgaard-Jones, Stephanie A Harris, Hazel Morrison, Alberta Ateere, Beatrice Nassanga, Raquel Lopez Ramon

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.
Iman Satti, Julia L Marshall, Stephanie A Harris, Rachel Wittenberg, Rachel Tanner, Raquel Lopez Ramon

Lancet Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2.
Helen E Higham, Lauren Morgan, Cushla Cooper, Julia Marshall, Andrew Mawer, Raquel Lopez-Ramon

Br J Clin Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Susan Jackson, Julia L Marshall, Andrew Mawer, Raquel Lopez-Ramon, Stephanie A Harris

Lancet Microbe· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat controlled human malaria infection of healthy UK adults with blood-stage : Safety and parasite growth dynamics.
Jo Salkeld, Yrene Themistocleous, Jordan R Barrett, Celia H Mitton, Thomas A Rawlinson, Raquel Lopez Ramon

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study.
Morven Wilkie, Rachel Tanner, Daniel Wright, Raquel Lopez Ramon, Julia Beglov

Sci Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.
Angela M Minassian, Yrene Themistocleous, Sarah E Silk, Jordan R Barrett, Alison Kemp, Raquel Lopez Ramon

JCI Insight· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Angela M Minassian, Sarah E Silk, Jordan R Barrett, Carolyn M Nielsen, Kazutoyo Miura, Raquel Lopez Ramon

Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy -Infected Adults.
Michael Riste, Julia L Marshall, Iman Satti, Stephanie A Harris, Morven Wilkie, Raquel Lopez Ramon

Vaccines (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Morven Wilkie, Iman Satti, Alice Minhinnick, Stephanie Harris, Michael Riste, Raquel Lopez Ramon

Vaccine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Zita-Rose Manjaly Thomas, Iman Satti, Julia L Marshall, Stephanie A Harris, Raquel Lopez Ramon

PLoS Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Alice Minhinnick, Iman Satti, Stephanie Harris, Morven Wilkie, Sharon Sheehan, Raquel Lopez-Ramon

Vaccine· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Iman Satti, Joel Meyer, Stephanie A Harris, Zita-Rose Manjaly Thomas, Kristin Griffiths, Raquel Lopez Ramon

Lancet Infect Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis